Before You Buy CBD Capsules Read This
October 16th, 2017
Cannabis legalization is favored by over 60% of the US, according to a new poll: it is no wonder that cannabis products for medical use are selling hand over fist. Given that easing restrictions on cannabis in many states, it is unsurprising that you can find hemp extracts on Amazon and CBD capsules with an internet search. Before jumping on a purchase of CBD or hemp capsules online, take note of the following warnings; CBD medicine ranges greatly in effectiveness and there is a tremendous amount of disinformation about CBD extracts and capsules.
The DEA Won’t Budge
Despite court rulings in favor of the Hemp Industries Association against the DEA that provide the loophole by which CBD and hemp extracts are sold “legally” online, the DEA has maintained their stance that CBD, regardless of whether it is derived from hemp or marijuana, is illegal in all 50 states according to the Controlled Substances Act (CSA). Hemp oil has been an import to the US for decades: the difference now, is that extracts made to include high levels of CBD are claimed by the DEA to be illegal, as the only way CBD could be derived from legal hemp, is if illegal marijuana pollens were to “stick” to hemp in fields. This position is absurd, as spectrometer tests on hemp stalks have shown that trace amounts of CBD are present within, and it is possible to extract that compound and refine it for potency. Nonetheless, the DEA is committed to maintaining the illegality of CBD, even when derived from industrial hemp (less than .3% THC).
Little, to No Oversight on Industry
Though CBD does have medicinal properties, many unscrupulous internet dealers market their CBD as medicinal despite it being so low in potency that the medicinal benefits won’t clearly manifest through normal use. As mentioned, industrial hemp contains less than .3% THC: though certain strains of hemp have higher amounts of CBD than THC, the potency and percentage amount of CBD within hemp will always fall short of marijuana, or “whole plant” derived CBD.
Due to the DEA’s stance of CBD capsules and products still being illegal under the CSA, purveyors of hemp extract and hemp-derived CBD use legal loopholes to market and sell their products online. This double-standard of legality leaves ambiguity when it comes to consumer protections. Despite arguing its illegality, the DEA is correct that marijuana-derived CBD is potent whereas hemp-derived extracts only contain a small percentage of actual CBD. Naturally, companies that sell CBD capsules claim that their hemp-derived CBD extracts are 99% pure and that they contain under .3% THC, making it legal to buy and sell. They also claim all of the medicinal benefits of CBD as benefits of their product, despite hemp-derived CBD being inferior to marijuana-derived CBD as medicine.
Bioavailability of CBD: How Well the Body Absorbs CBD
In addition to the wide difference between potency of CBD derived either from hemp or marijuana that may leave some consumers with no benefit for taking hemp or CBD capsules, the uptake of CBD into the human body varies tremendously depending on how the capsules are taken. According to Endoca.com, oral consumption of CBD allows only 6% of the compound to be processed into the body. While dogs can process 13-19% of the CBD in the same dose, humans do not orally process CBD nearly as well. When inhalation is the method of intake of CBD, such as in vaporized form, 31% of the compound makes it into the endocannabinoid system. Though some CBD capsules will contain oil that can be vaporized with the right equipment, inferior quality CBD capsules and oil can be contaminated, resulting in adverse effects to the lungs if vaped. In the form of sublingual delivery, CBD uptake to the body was higher than when taken orally, but not as effective as inhalation. For rectal intake, roughly 13.5% of the compound makes it through the body’s processes in order to be medicinally effective.
CBD capsules may seem like a medicinally sound and non-toxic way to mitigate a handful of ailments ranging from inflammation, pain relief, quitting smoking, treating cancer, managing epileptic outbursts, or treating mental illnesses and anxiety disorders: before jumping to buy any old hemp-derived CBD capsule, do your research first. Trust reputable brands that have plenty of positive reviews online. Ideally, find spectra-analysis results of the CBD product that you’re considering purchasing: it is possible to determine whether a product contains high or low levels of actual CBD, so research before buying to ensure that you get the most “bang” for your buck.
Don’t get sucked into deceptive marketing tactics and exaggerated promises: know before spending your hard-earned money on CBD capsules that marijuana-derived CBD oil and capsules will always be more medicinally valid than hemp-derived CBD, and that hemp-derived CBD products vary tremendously in potency and effectiveness.
Follow Us on Social Media
About CFN Media
CFN Media (CannabisFN) is the leading creative agency and media network dedicated to legal cannabis. We help marijuana businesses attract investors, customers (B2B, B2C), capital, and media visibility. Private and public marijuana companies and brands in the US and Canada rely on CFN Media to grow and succeed.
CFN launched in June of 2013 to initially serve the growing universe of publicly traded marijuana companies across North America. Today, CFN Media is also the digital media choice for the emerging brands in the space.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: http://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: http://www.cannabisfn.com/legal-disclaimer/.